Irwin Naturals Inc. (IWINF)
| Previous Close | 3.3900 |
| Open | 3.0500 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.8000 - 3.0580 |
| 52 Week Range | 0.8000 - 3.9700 |
| Volume | |
| Avg. Volume | 1,208 |
| Market Cap | 4.504M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 298.40 |
| EPS (TTM) | 0.0100 |
| Earnings Date | Aug 30, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.33 |
- GlobeNewswire
Irwin Naturals Secures $40 Million of Financing for its Current Operations including Psychedelic Mental Health Clinic Rollup, Potential for up to $60 Million
LOS ANGELES, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that the Company has secured a credit facility as of February 1, 2023 with its existing commercial lender for up to $60 million with $40 million of it currently committed. The rate shall be variable based on the margins of the credit facilities. Half of the facility is in place until August 2024, with a maturity date of February 2028, while half of fac
- GlobeNewswire
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific
Strategic transaction assembles an experienced management and scientific team world-renowned in the mental health treatment, research and development.Establishes large footprint of 22 specialized mental health clinics across North America, enhanced by a telehealth platform expected to extend access to critical treatments for millions of people across multiple states in the US.Combined network of clinics creates a leading international mental health research platform for in-human clinical develop
- Baystreet
Stocks in play: Irwin Naturals Inc
Announces it has entered into a non-binding amended and restated Letter of Intent for a business combination ...
